Clinical Trial Update: Will Decreased Noradrenergic Activity Normalize Information Processing in Patients With Schizophrenia? [NA]

View source ↗

Summary

A completed clinical trial evaluating whether decreased noradrenergic activity can normalize information processing in patients with schizophrenia.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Schizophrenia

Snippet

Sponsor: Birte Glenthoj | Conditions: Schizophrenia | NA | Status: COMPLETED